Mon panier

LAP (TGF-beta 1)

LAP (TGF-beta 1) Informations sur la molécule

Nom anglaisTransforming growth factor beta 1Nombre de médicaments commercialisés1
Nombre de médicaments cliniques22Alias de la cibleLatency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Phase de R&D la plus avancéeApproved
Nom anglaisTransforming growth factor beta 1
Alias de la cibleLatency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Nombre de médicaments commercialisés1
Nombre de médicaments cliniques22
Phase de R&D la plus avancéeApproved

LAP (TGF-beta 1) Liste de produits

  • Attribut

    Protein (4)

  • Bibliothèque de produits

    En ligne (4)

  • Espèces

    Human (4)

  • Étiquette

    His Tag (1)His Tag & Avi Tag (1)Tag Free (1)Fc Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (2)Biotin-labeled (2)

LAP (TGF-beta 1)Contexte de la molécule

Transforming growth factor beta 1 ( TGFB1) is also known as TGF-β1, CED, DPD1, TGFB. is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis. The TGFB1 protein helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (motility), and the self-destruction of cells (apoptosis). The TGFB1 protein is found throughout the body and plays a role in development before birth, the formation of blood vessels, the regulation of muscle tissue and body fat development, wound healing, and immune system function. TGFB1 is particularly abundant in tissues that make up the skeleton, where it helps regulate bone growth, and in the intricate lattice that forms in the spaces between cells (the extracellular matrix). Within cells, this protein is turned off (inactive) until it receives a chemical signal to become active. TGFB1 plays an important role in controlling the immune system, and shows different activities on different types of cell, or cells at different developmental stages. Most immune cells (or leukocytes) secrete TGFB1. TGFB1 has been shown to interact with TGF beta receptor 1, LTBP1, YWHAE, EIF3I and Decorin.

LAP (TGF-beta 1)Alias de la molécule

LAP (TGF-beta 1),LAP (TGFB1),TGFB1,CED,DPD1,LAP,TGF-beta-1,TGFB

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
VactosertibTEW-7197; EW-7197; NOV-1301Phase 3 ClinicalMedpacto IncAdenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Solid tumours; Stomach Neoplasms; Urologic Neoplasms
Details
Bintrafusp alfaM-7824; GSK-4045154; MSB-0011359CPhase 3 ClinicalMerck SeronoAnus Neoplasms; Biliary Tract Neoplasms; Brain metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Esthesioneuroblastoma, Olfactory; Gallbladder Neoplasms; Ganglioglioma; Head and Neck Neoplasms; Hematologic Neoplasms; Intestinal Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Microsatellite Instability; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Germ Cell and Embryonal; Nose Neoplasms; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Penile Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Respiratory papillomatosis; Sarcoma; Sarcoma, Kaposi; Skin Melanoma; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thymic epithelial tumor; Thymoma; Thymus Neoplasms; Triple Negative Breast Neop
Details
NisevokitugNIS-793Phase 3 ClinicalXoma CorpAdenocarcinoma; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
Details
Yinfenidone HydrochlorideHEC-585; HEC-00000585Phase 3 ClinicalHec Pharm Co LtdIdiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis
Details
SB-01 (Ensol BioSciences)Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2KPhase 3 ClinicalEnsol Biosciences IncIntervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain
Details
LivmoniplimabMGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115Phase 3 ClinicalArgenx SeCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Solid tumours
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncCarcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
ZSP-1603ZSP-1603Phase 2 ClinicalGuangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Neoplasms; Ovarian Neoplasms; Solid tumours; Thyroid Neoplasms
Details
NicousamideXLF-III-43Phase 2 ClinicalInstitue Of Materia Medica Chinese Academy Of Medical ScienceDiabetic Nephropathies; Hypertensive nephropathy
Details
Meflonidone hydrochloridePhase 2 ClinicalCentral South University, Guangzhou Nanxin Pharma Co LtdDiabetes Mellitus, Type 2; Diabetic Nephropathies
Details
FluorofenidoneAKF-PDPhase 2 ClinicalCentral South University, Dierepharma HK Ltd, Hainan Haiyao Co LtdHepatitis B, Chronic; Liver Cirrhosis
Details
CotsiranibSTP-705LU; STP-705LV; STP-705; STP-705LPhase 2 ClinicalSirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co LtdCarcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cicatrix, Hypertrophic; Keloid; Liver Neoplasms; Obesity, Abdominal
Details
YL-13027YL-13027Phase 2 ClinicalYL-PharmaPancreatic Neoplasms; Solid tumours
Details
MR-001MR001; MR-001Phase 2 ClinicalShenzhen Maijiarui Biotechnology Co LtdCarcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
LinavonkibartSRK-181; SRT-BETA-1-AB3Phase 1 ClinicalScholar Rock IncNeoplasms
Details
Charis-1000Charis-1000; C 1K; C1KPhase 1 ClinicalEnsol Biosciences IncBreast Neoplasms
Details
HLX-6018HLX-6018; HLX6018Phase 1 ClinicalIdiopathic Pulmonary Fibrosis
Details
RO7496353RO7496353; RO-7496353; SOF 10; RG6440; RG-6440Phase 1 ClinicalGenentech IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours; Stomach Neoplasms
Details
JYB-1907JYB-1907Phase 1 ClinicalJiangxi Jemincare Group Co LtdSolid tumours
Details
STP-707STP-707; STP707Phase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co LtdCholangitis, Sclerosing; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms; Pulmonary Fibrosis; Solid tumours
Details
PXS-64PXS-64Phase 1 ClinicalSyntara LtdMultiple Sclerosis
Details
BMS-986416BMS-986416; AVID-200 DP; AVID-200Phase 1 ClinicalFormation Biologics CorpPolycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Tonogenchoncel-LTG-CApprovedTissuegeneInvossa-K, InvossaSouth KoreaOsteoarthritisnull2017-07-01Intervertebral Disc Degeneration; Osteoarthritis; Osteoarthritis, Knee
Details

Avis sur les produits

  • J***s2025-07-22
    0Mettre un like
    The Human LAP (TGF-beta 1) Protein, Tag Free, is a high-quality recombinant protein ideal for cell signaling studies and bioassays. It exhibits excellent purity and biological activity, ensuring reliable experimental results. The tag-free format supports native protein function, making it suitable for a wide range of applications in immunology and cell biology. Consistent performance and dependable results.
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments commercialisés
  • Avis sur les produits
  • Informations sur les médicaments cliniques